Loading...

Johnson & Johnson

JNJ•NYSE
Healthcare
Drug Manufacturers - General
$227.50
$-3.15(-1.37%)
U.S. Market opens in 15h 23m

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap548.1B
P/E Ratio26.51
EPS (TTM)$11.04
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$227.93
3 Months$258.08
1 Year Target$179.28

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.28.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.51 and a market capitalization of 548.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.39%
5-Day Change
-2.95%
1-Month Change
-3.33%
3-Month Change
3.32%
6-Month Change
19.45%
Year-to-Date (YTD) Change
9.90%
1-Year Change
46.80%
3-Year Change
38.95%
5-Year Change
38.58%
All-Time (Max) Change
18542.62%

Contact Information

https://www.jnj.com
732 524 0400
One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Company Facts

138,100 Employees
IPO DateJan 2, 1943
CountryUS
Actively Trading

Frequently Asked Questions